Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP19980204331external-prioritypatent/EP0924958B1/en
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Priority claimed from PCT/EP1999/004545external-prioritypatent/WO2000001411A1/en
Publication of NZ509646ApublicationCriticalpatent/NZ509646A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Described is the use of a farnesyl protein transferase inhibitor for the preparation of a pharmaceutical composition having radiosensitising properties for administration before during or after irradiation of a tumour for treating cancer, wherein the inhibitor is a compound of formula (I), (II) or (III).
NZ509646A1998-07-061999-06-30Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
NZ509646A
(en)